Hoyt Casey 4

What Happened
Hoyt Casey, CEO of Viemed Healthcare (VMD), reported the vesting/settlement of derivative awards on Jan 21, 2026. A total of derivative units converted (reported as “exercise or conversion of derivative”) including 49,597 and 12,400 units. To cover taxes and settle the cash-settled units, 13,565 shares were withheld (tax withholding) valued at $7.49/share (~$101,602), and 12,400 underlying shares were simultaneously sold/disposed to the issuer at $7.49/share for $92,876. Combined reported cash value from the withholding and sale is about $194,478. These transactions were compensation-related (vesting/settlement), not open-market purchases.

Key Details

• Transaction date: January 21, 2026; Form 4 filed January 23, 2026 (appears timely). Per-share value shown is the market close price on Jan 21, 2026 ($7.49) (F3).
• Reported movements: conversions/exercises of 49,597 and 12,400 derivative units; 13,565 shares withheld for taxes (F2) and 12,400 shares disposed to issuer for cash (D).
• Cash/result: tax withholding ~ $101,602; sale to company $92,876; total ~$194,478.
• Shares owned after transaction: not specified in the provided excerpt.
• Notable footnotes: RSUs equal one share each (F1); phantom share units are cash-settled equivalents of common shares and were settled for cash (F4); the RSUs and phantom awards were grants from Jan 21, 2025 that vest in three equal annual installments (F5, F6).

Context

• These were vesting/settlement transactions (compensation-related). The phantom-share units were cash-settled, meaning the company paid cash for economic value rather than issuing new shares; some RSU shares were withheld to cover tax obligations.
• Such transactions are routine insider compensation events and do not necessarily signal a personal buy or sell decision in the open market.